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Abstract
The stereoselective synthesis of truxillic bis-amino esters from polyfunctional oxazolones is reported. The reaction of 4-((Z)-aryli-
dene)-2-(E)-styryl-5(4H)-oxazolones 2 with Pd(OAc)2 resulted in ortho-palladation and the formation of a dinuclear open-book
complexes 3 with carboxylate bridges, where the Pd atom is C^N bonded to the oxazolone. In 3 the two exocyclic C=C bonds of
the oxazolone are in a face-to-face arrangement, which is optimal for their [2 + 2] photocycloaddition. Irradiation of dimers 3 in
CH2Cl2 solution with blue light (465 nm) promoted the chemo- and stereoselective [2 + 2] photocycloaddition of the exocyclic
C=C bonds and the formation of cyclobutane-containing ortho-palladated complexes 4. Treatment of 4 with CO in a MeOH/NCMe
mixture promoted the methoxycarbonylation of the palladated carbon and the release of the corresponding ortho-functionalized 1,3-
diaminotruxillic bis-amino esters 5 as single isomers.
Introduction
Truxillic acid derivatives (Figure 1a) are a special family of
cyclobutanes that have been known since 1888 and show prop-
erties of high interest [1]. In this respect, their pharmacological
activity has prompted extensive research that has focused on
both their synthesis and the different pharmacological targets.
Among them, probably the most important is their remarkable
intrinsic anti-inflammatory and antinociceptive action, for
which some mechanisms have been postulated to explain this
activity [2-6]. The interest in this type of compound has gained
even more relevance in the last few years due to the discovery
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Figure 1: (a) General scheme for truxillic acid derivatives; (b) general scheme for symmetric 1,3-diaminotruxillic ester derivatives; (c) retrosynthesis:
4-arylidene-5(4H)-oxazolones are optimal precursors.
Figure 2: (a) (Z)-4-Arylidene-2-aryl-5(4H)-oxazolones used for the synthesis of 1,3-diaminotruxillic derivatives by direct [2 + 2] photocycloaddition of
the exocyclic C=C bond or by incoporation of Pd to the oxazolone skeleton through C–H activation followed by [2 + 2] photocycloaddition; (b) (Z)-4-
arylidene-2((E)-styryl)-5(4H)-oxazolones studied in this work with all synthetic possibilities shown.
that truxillic acid derivatives are inhibitors of FABP (fatty acid
binding proteins), which are responsible for the cellular reup-
take of anandamide, an endocannabinoid neurotransmitter, and
that they can be involved in a very efficient treatment for
chronic pain [7-10]. Moreover, alternative mechanisms to
explain the antinociception of truxillic compounds have also
been reported [11,12] and have generated intense debate. In ad-
dition, truxillic derivatives have shown remarkable activity as
hepato-protective agents [13] and they also have applications as
internal donors in Ziegler–Natta catalysts for polymerization
[14] or as building blocks in polymer chemistry [15].
A very closely related group of cyclobutanes are the 1,3-
diaminotruxillic ester derivatives (Figure 1b). This type of bis-
amino esters also shows remarkable pharmacological
activity, not only as antinociceptive drugs but also in the
treatment of type 2 diabetes mellitus. In fact, recent results
have shown that these compounds are the only non-peptidic
agonists of the GLP-1R (glucagon-like peptide 1 receptor) and
they have a higher stability than any other agonist prepared to
date [16-18]. The properties outlined above highlight the impor-
tance of the wide scope of applications of this set of cyclobu-
tanes.
Despite their importance, access to most of these compounds
mainly relies in the well-known [2 + 2] photocycloaddition of
olefins [19]. Unfortunately, the synthesis of truxillic or
diaminotruxillic derivatives is far from being a highly efficient,
selective and general process. Two different cases are usually
found in the literature: (a) the direct [2 + 2] photocycloaddition
of the corresponding olefins takes place, but shows poor effi-
ciency (long reaction times, harsh irradiation conditions and
low yields) [16,20], or (b) the direct [2 + 2] cycloaddition does
not take place and it is necessary to synthesize a cyclobutane
precursor and then functionalize it, thus increasing the number
of reaction steps, the waste material, and decreasing the global
yield [16,21]. Another drawback of these reactions is the selec-
tivity, because good selectivity is achieved in photocycloaddi-
tions in solid state provided that the topochemical Schmidt's
conditions are met [22-24], but the selectivity in solution is
usually not as high [25,26].
Our group is interested in the synthesis of 1,3-diaminotruxillic
derivatives and we have made some contributions to this area of
research [27-30]. Firstly, we demonstrated that (Z)-4-arylidene-
2-aryl-5(4H)-oxazolones (Figure 2a) are excellent precursors
for the synthesis of this type of derivative, both by irradiation of
the free species [27] and on using Pd complexes as templates
[28-30]. The latter approach has shown good potential as a syn-
thetic tool because it allows 1,3-diaminotruxillic derivatives to
be obtained in a fully regio- and stereoselective way (only the
ε-isomer is obtained). The process requires very mild reaction
conditions in only three steps, with moderate to high yields in
short reaction times under flow conditions [29], and it is com-
patible with substituents with different electronic properties
(electron-releasing or electron-withdrawing) in the 4-arylidene
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Figure 3: (Z)-4-Arylidene-2((E)-styryl)-5(4H)-oxazolones 2a–j used in this work and overall reaction scheme.
ring. In addition, the ortho-position of the 2,4-aryl rings in the
resulting bis-amino acids can be functionalized [30].
Substrates of the (Z)-4-arylidene-2((E)-styryl)-5(4H)-oxazolone
type, shown in Figure 2b, are interesting starting materials for
the synthesis of new 1,3-diaminotruxillic derivatives. These
azlactones are precursors of the photoconvertible chromophore
of the Kaede protein, an imidazolone with outstanding photo-
physical properties [31-38]. It is clear from Figure 2b that the
molecular skeleton contains different reactive functional
groups, which offer a variety of structural possibilities: two dif-
ferent competitive C=C bonds amenable to undergo photocyclo-
addition and at least three different C–H bonds that can be acti-
vated by a transition metal provide the potential for a rich
organic and organometallic chemistry. Moreover, both the aryli-
dene and the styryl groups can be tuned with different substitu-
ents to control the electronic and steric requirements of the
ligand. We focused on precursors that have functional groups of
interest (F, Cl, CF3, NO2) as substituents in the 4-arylidene
ring. In this way the final products will contain either a func-
tional group that can be reacted further (for instance C–Cl,
C–NO2) or a functional group of interest from the medicinal or
agrochemical point of view (for instance C–CF3, C–F) [39-41].
However, their reactivity is still totally unexplored in terms of
both [2 + 2] photocycloaddition and metallations through C–H
bond activations. In the present contribution we report the
results obtained for these two different processes.
Results and Discussion
Synthesis and characterization of the (Z)-4-
arylidene-2((E)-styryl)-5(4H)-oxazolones 2
The synthesis of the oxazolones 2 was carried out following the
well-known Erlenmeyer–Plöchl method (Figure 3), by reaction
of N-cinnamoylglycine (1) with the corresponding benzalde-
hyde ArCHO in acetic anhydride as solvent and in the presence
of sodium acetate [42-48]. In turn, N-cinnamoylglycine (1) was
prepared following the Schotten–Baumann method from
glycine and cinnamoyl chloride [49]. All of the oxazolones used
in this work are shown in Figure 3. The synthesis is quite
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Scheme 1: Ortho-palladation of oxazolones 2 by treatment with Pd(OAc)2 and different structures obtained for ortho-palladated complexes 3.
general and tolerates substituents at different positions of the
4-arylidene ring, although the yields are only moderate to low.
The lowest yields correspond to ortho-substituted substrates,
which suggests that steric hindrance plays a role during the
reaction. Oxazolones 2a–j contain two exocyclic C=C bonds in
their skeleton and these can, in principle, have different confor-
mations. The NMR characterization of 2a–j showed that they
are obtained as single isomers. The oxazolone exocyclic C=C
bond has the (Z)-configuration, because the signal assigned to
the C=O group appears as a doublet in the proton-coupled
13C NMR spectrum, with a 3JCH coupling constant of 5.6 Hz
[50]. In contrast, the C=C bond of the styryl group has an (E)-
configuration, as inferred from the observation of a 3JHH cou-
pling constant of 16 Hz between the two olefinic protons of the
styryl fragment.
Further characterization of the new oxazolones was provided by
the determination of the crystal structure of oxazolone 2c. A
molecular drawing of 2c is shown in Figure 4, where the (Z)-
configuration of the exocyclic C=C bond (C7–C8) and the (E)-
configuration of the styryl moiety (C11–C12) are clearly seen,
thus confirming the results obtained in solution. It is worth
noting the orientation of the chlorine atom Cl1, which is syn
with respect to the benzylidene proton. This orientation mini-
mizes steric repulsions in the molecule and allows the establish-
ment of an intramolecular contact between Cl1 and H7A. The
non-bonding distance Cl1–H7A is 2.565(3) Å, which is much
shorter than the sum of the van der Waals radii (2.95 Å) [51].
The same syn arrangement between the ortho-substituent and
the benzylidene proton has also been observed in related ortho-
substituted unsaturated 4-arylidene-oxazolones [52-59]. The
internal bond distances and angles for the 4-arylidene fragment
and the oxazolone ring are similar or identical, within experi-
mental error, to those found in related oxazolones reported in
the literature [52-59]. The styryl fragment bonded to an
oxazolone ring has not been characterized previously by X-ray
methods, but it shows internal bond distances and angles simi-
lar to those found in related 2-styrylimidazolone species [60].
Figure 4: Molecular drawing of the oxazolone 2c.
C–H Bond activation processes on (Z)-4-
arylidene-2((E)-styryl)-5(4H)-oxazolones 2
Once the starting oxazolones 2 had been prepared, their direct
[2 + 2] photocycloaddition was attempted. However, irradiation
of solutions of 2 in CD2Cl2 with blue LED light (465 nm),
under the same conditions as reported previously by us for simi-
lar oxazolones [27], did not produce the expected cyclobutanes
or gave only very low conversions (<5%) after long reaction
times (96 h). As this reactivity was poor, it was decided to
attempt the reaction using Pd complexes as templates [28-30].
The first step in this process was to study the C–H bond activa-
tion in oxazolones 2 promoted by Pd(OAc)2, which shows
multiple possibilities (Figure 2b).
Treatment of the oxazolones 2a–j with Pd(OAc)2 (1:1 molar
ratio) in CF3CO2H as solvent under reflux for 2 h resulted in
the formation of the dinuclear complexes 3a–f and 3h–j, as
shown in Scheme 1. In the case of oxazolone 2g a very com-
plex mixture was obtained and a pure compound could not be
isolated.
Beilstein J. Org. Chem. 2020, 16, 1111–1123.
1115
Scheme 2: [2 + 2] Photocycloaddition of cyclopalladated complexes 3 in solution to give the dinuclear cyclobutane ortho-palladated complexes 4.
Complexes 3 were obtained as air- and moisture-stable solids in
good yields (see Experimental and Supporting Information
File 1). In general, the yields were higher than 85%, which
shows that the C–H activation is a general process and that the
presence of strong electron-withdrawing groups is not an
obstacle for the synthesis of the ortho-palladated derivatives.
Only in the case of complexes 3e and 3i were the yields slightly
lower than in the other cases (70% and 66%, respectively),
probably due to two simultaneous factors, namely the presence
of bulky CF3 and NO2 groups in ortho positions of the starting
oxazolones 2e and 2i, and the strongly deactivating effect of the
two groups on the C–H bond activation process. The reactions
were usually carried out using 0.6 mmol of the starting material
2. In this respect, it is remarkable that the C–H activation allows
in this case scale-up of the reaction without a loss of yield. For
oxazolone 2h the reaction was carried out using 4.3 mmol of
starting material and the final yield of analytically pure 3h was
94% (see Experimental).
The characterization of complexes 3 shows that they are ob-
tained as dinuclear derivatives, as inferred from the HRMS
spectra. The oxazolone is bonded to the Pd(II) center as a C,N-
chelate, as inferred by analysis of the 1H NMR spectra. The
spectra show that the spin system of the styryl fragment
–C(H)=C(H)Ph remains unaltered after the reaction, while the
spin system of the 4-arylidene fragment (R–C6H4–C(H)=)
changed to R–C6H3–C(H)=, thus showing the loss of one ortho-
H. This strongly suggests that the C–H bond activation and in-
corporation of the Pd atom had occurred chemo- and regioselec-
tively at the 4-arylidene ring. The same conclusions can be
drawn from the analysis of the 13C NMR spectra, where the
presence of the PdC6H3R–C(H)= group is clear. Therefore, the
orientation of the C–H activation in these 4-aryliden-2-styryl-
oxazolones is exactly the same as that observed for the
4-aryliden-2-aryloxazolones [28-30,56]. Signals corresponding
to the activation of other C–H bonds present in oxazolones 2
(styryl, aryl) were not observed, so the reaction shows full
selectivity towards the ortho-arylidene positions despite the
presence of different C–H bonds that could be activated.
Considering the dinuclear nature of compounds 3, the C,N-
chelate bonding mode of the ortho-palladated oxazolone and the
ability of the carboxylate group to act as a bridging ligand in
related complexes, we propose for complexes 3a–f and 3h–j the
‘open-book’ structure shown in Scheme 1.
The dimeric open-book structures of 3 can result in the forma-
tion of two isomers, the transoid (in which the two cyclopalla-
dated oxazolones are in an anti arrangement) and the cisoid (syn
arrangement). The presence of the two isomers in 3 is clear
from the observation of two sets of signals due to the CF3CO2–
ligand in the 19F NMR spectra. The major isomer shows one
singlet and this is assigned by symmetry to the transoid isomer,
while the minor isomer shows two singlets and is assigned to
the cisoid isomer. The transoid isomer is always the most abun-
dant one, with transoid/cisoid ratios in the range from 70:30
(3i) to 96:4 (3h). Only the major transoid isomer in the mixture
was fully characterized (see Experimental).
Reactivity of ortho-palladated complexes 3
with light: intramolecular [2 + 2]
photocycloaddition
Despite the lack of reactivity of free oxazolones 2 with blue
light (465 nm), irradiation of the ortho-palladated complexes 3
with light of the same wavelength afforded better results. The
irradiation of dinuclear derivatives 3a–f and 3h–j in CH2Cl2
solution with blue light (465 nm), provided by low-power LED
lamps, took place with chemoselective [2 + 2] photocycloaddi-
tion of the oxazolone exocyclic C=C bonds and formation of the
corresponding ortho-palladated cyclobutane derivatives 4a–f
and 4h–j, as shown in Scheme 2.
Complexes 4a–f and 4h–j were obtained as air- and moisture-
stable solids in good to very good yields. This also applied to
the synthesis of 4h, which was performed at scale of 2 mmol
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Figure 5: Molecular drawing of cyclobutane ortho-palladated 4a. Ellipsoids are shown at the 50% probability level.
(instead of 0.2 mmol in most of the other cases) and was ob-
tained with 96% isolated yield. In order to understand the dif-
ferent reactivities of oxazolones 2 and complexes 3 towards
light, the absorption UV–vis spectra of the oxazolones 2 and
ortho-palladated complexes 3 (CH2Cl2, 5 × 10−4 M) were
measured and this provided some clues. The positions of the
absorption maxima (λmax, nm) for both species are collected in
Table 1.
Table 1: UV–vis spectra of 2 and 3: absorption maxima (λmax, nm).










According to the data in Table 1, the maximum absorption for
oxazolones 2 is located in the near UV region, in the range of
375–385 nm, and this is quite far from the irradiation wave-
length (465 nm). In fact, at 465 nm the UV–vis spectra of
oxazolones 2 show that the absorption is zero or close to zero.
Therefore, the lack of reactivity of species 2 can be related with
the absence of the absorption of light. However, the ortho-palla-
dation causes a clear bathochromic shift from compounds 2 to 3
and this results in absorption maxima for complexes 3 located
in the range of 454–467 nm. In this case the use of blue light
(465 nm) is optimal for their irradiation, because the irradiation
wavelength matches the maximum absorption.
NMR characterization of complexes 4 showed that all com-
pounds were obtained as a single stereoisomer, despite the pres-
ence of two isomers in the starting materials 3. The 1H NMR
and 13C NMR spectra clearly showed the chemical equivalence
of the two ortho-palladated fragments, while 19F NMR spectra
showed the equivalence of the bridging trifluoroacetate ligands.
This means that only the transoid isomers of complexes 3 were
transformed into cyclobutanes 4, as shown in Scheme 2. The
small amount of cisoid isomer in 3 probably decomposed under
the reaction conditons, because in some cases the presence of
small amounts of black Pd0 was observed. The formation of the
cyclobutane ring is inferred in the 1H NMR spectra from the
disappearance from the aromatic region of the signal due to the
vinyl proton of the oxazolone exocyclic C=C bond and the ap-
pearance of a new singlet in the 4.8–5.7 ppm region. Further ev-
idence can be found in the 13C NMR spectra, where the two
peaks due to the exocyclic C(H)=C bond disappeared and two
new signals appeared at around 68–69 ppm (quaternary C) and
51–60 ppm (CH). These facts are consistent with the expected
hybridization change from Csp2 to Csp3 after formation of the
cyclobutane ring.
Determination of the crystal structure of complex 4a, which is
shown in Figure 5, provides additional information. Complex
4a has a dinuclear structure in which each Pd atom is
surrounded by one C,N-ortho-metallated oxazolone and two
oxygen atoms of the trifluoroacetate ligands, which act as
bridging ligands between the two Pd(C^N) fragments. In turn,
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the two Pd(C^N) fragments are linked by the cyclobutane ring
formed by [2 + 2] photocycloaddition of the oxazolone
exocyclic C=C bonds. The resulting configuration of the
C3–C4–C3'–C4' cyclobutane ring, in which the carbonyl groups
are on one side of the plane containing the cyclobutane and the
nitrogen and the ortho-palladated ring on the other side of the
plane, shows that the compound obtained is the epsilon (ε)
isomer, according to the classification of Stoermer [61,62]. The
non-bonding intramolecular distance between the ortho-fluo-
rine F1 and the cyclobutane proton H4 is d(F1...H4) =
2.286(3) Å, which is much shorter than the sum of the van der
Waals radii (2.67 Å) [51]. This suggest a close interaction be-
tween these two atoms, as observed in the crystal structure of 2c
(see above). The analysis of other internal bond distances and
angles in the coordination sphere of the Pd atom shows that
they are similar to those found in related examples reported in
the literature and do not show additional noteworthy features
[28-30].
From the observation of the molecular structure of 4a, it is clear
how the geometrical constraints of the ligands in complexes 3
establish unequivocally the stereoselective formation of the
ε-isomer in 4: (1) the initial (Z)-configuration of the oxazolones
2 is retained during the C–H bond activation step to give 3;
(2) the relative transoid arrangement in 3 establishes the 1,3-
head-to-tail coupling of the exocyclic C=C bonds; (3) the tem-
plate effect of the Pd2(O2CCF3)2 moiety establishes the syn ap-
proach of the C=C bonds. As a result, only the ε-isomer can be
obtained and the stereoselectivity of the method is complete. As
discussed previously, photocycloaddition products from the
[2 + 2] reaction of the cisoid isomers of 3 were not observed,
and we are unaware of the reasons for this lack of reactivity.
Release of the 1,3-truxillic derivative by
methoxycarbonylation
The last step to achieve the synthesis of the 1,3-diaminotrux-
illic targets was the release of the cyclobutane from the
Pd2(O2CCF3)2 template. We previously reported that hydroge-
nation and halogenation were adequate tools to liberate 1,3-
diaminotruxillics from the organopalladium template [29,30].
We employed similar reactions in this case with complexes 4,
but none of the attempts gave satisfactory results. Therefore, we
discarded them and investigated other alternatives.
We found that the reaction of ortho-palladated complexes 4
with CO in methanol is a good option to promote the liberation
of the organic cyclobutane, while retaining the functionalities
already present (C–F, C–Cl, C–NO2, C–CF3 and –C(H)=C(H)–
groups) and introducing a new functionality, i.e., the methoxy-
carbonyl group, selectively at the ortho-position of the aryl
rings bonded to carbons C2 and C4 of the cyclobutane. Alkoxy-
carbonylation is a well-known reaction in Pd(II) chemistry [63-
66]. Therefore, treatment of solutions of cyclobutanes 4 in a
mixture of MeOH/NCMe (1:3) with CO (1 atm) at room tem-
perature proceeded with decomposition of the organometallic
core, precipitation of black Pd0 and concomitant formation of
the cyclobutanes 5, as represented in Scheme 3.
Scheme 3: Release of the 1,3-diaminotruxillic bis-amino ester deriva-
tives 5 by methoxycarbonylation of the Pd–C bond in cyclobutanes 4
and reductive elimination.
The methoxycarbonylation reaction to give 5 was not as general
as the previous steps to give oxazolones 2 or cyclopalladated 3
and 4. In the case of para- or meta-aryl-substituted derivatives 4
(4b, 4d, 4f, 4h and 4j) the reaction gave the corresponding
cyclobutanes (5b, 5d, 5f, 5h and 5j) in moderate to good yields,
but in the cases of the ortho-substituted compounds (4a, 4c, 4e,
4i) intractable mixtures were obtained. The presence of two
ortho-substituents in both aryl rings of the cyclobutanes (at C2
and C4) probably resulted in a strong steric hindrance around
the already crowded cyclobutane ring, which gave rise to insta-
bility and decomposition. However, it is remarkable that all
functional groups present in the starting materials 4 (C–F, C–Cl,
C–NO2, C–CF3 and –C(H)=C(H)–) remained intact after the
reaction, even in the presence of stoichiometric amounts of Pd0.
The presence of NCMe in large amounts in the reaction medi-
um is critical. The reaction in methanol takes place at a very
low rate but this increases markedly when NCMe is present.
After a short screening of MeOH/NCMe ratios it was found that
1:3 was optimal. The 1H NMR spectrum of complex 4h in
NCMe/NCMe-d3 shows the presence of Pd-coordinated NCMe,
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which suggests that the role of the NCMe is the decoordination
of the bridging carboxylate ligands by ligand exchange. The
substitution of the bridging CF3CO2 by monodentate NCMe
probably destabilizes the compact dinuclear scaffold, thus
helping the coordination and further reactivity of CO. Neverthe-
less, the reaction is slow because it took about 16 h to reach
completion. The reaction temperature is also critical, since room
temperature is necessary in order to obtain a clean release of the
truxillic esters. In addition to the methoxycarbonylation of the
Pd–C, the reaction also involves ring opening of the oxazolone
moiety to afford the corresponding ester and amido groups. This
ring opening was also observed in the case of the hydrogena-
tion and probably minimizes the steric strain around the cyclo-
butane ring.
The characterization of cyclobutanes 5 was performed by the
usual methods. The HRMS spectra confirmed the loss of the
Pd2(O2CCF3)2 unit and showed isotopic patterns in perfect
agreement with the proposed stoichiometries. The 1H NMR
spectra show in all cases the presence of two different CO2Me
units and one N(H)C(O)C(H)=C(H)Ph moiety, thus demon-
strating the incorporation of the methoxycarbonyl group and the
ring opening of the oxazolone by methanol. The expected
signals for the aryl and cyclobutane rings are also observed.
These findings were also confirmed by analysis of the
13C NMR spectra.
Conclusion
The synthesis of cyclobutane 1,3-diaminotruxillic bis-amino
acids has been achieved with full stereoselectivity (ε-isomer)
starting from polyfunctional oxazolones 2 derived from the
chromophore of the Kaede protein in three steps. The new (Z)-
4-arylidene-2-(E)-styryl-5(4H)-oxazolones 2 react with
Pd(OAc)2 through a C–H bond activation reaction to give the
dinuclear ‘open-book’ ortho-palladated complexes [Pd2(μ-
O2CCF3)2(C^N-oxa))2] 3 with bridging carboxylate ligands.
Despite the presence in 2 of different functional groups and dif-
ferent types of C–H bonds that could be activated, the C–H acti-
vation takes place regioselectively at the ortho-position of the
4-arylidene ring and leaves the remaining functional groups
(C–F, C–Cl, C–NO2, C–CF3, C(H)=C(H)) intact. The ‘open-
book’ complexes 3 show a face-to-face arrangement of the
exocyclic C=C bonds of the oxazolone, which is optimal for
their [2 + 2] photocycloaddition. Accordingly, irradiation of 3
with blue light (465 nm) results in the regioselective formation
of the corresponding dinuclear ortho-metallated cyclobutane
complexes 4, which contain the skeleton of the 1,3-
diaminotruxillic bis-amino acids. The reaction of the cyclobu-
tanes 4 with CO (1 atm) in MeOH/NCMe results in the ring
opening of the oxazolone group, methoxycarbonylation of the
Pd–C bonds, reductive elimination, and finally release of the
1,3-diaminotruxillic bis-amino esters 5 as single isomers
(ε-isomer).
The method shows great synthetic potential due to the selective
formation of a single isomer, versatility and efficiency (high
yields), general applicability and tolerance to the presence of
different functional groups, although it is partially limited by
steric hindrance in the final step. In addition, this approach




Solvents were obtained from commercial sources and used
without further purification. All reactions were performed with-
out special precautions against water and moisture. Thin-layer
chromatography (TLC) was performed on Macherey-Nagel
Polygram® SIL G/UV254 silica gel on polyester sheets, with
manganese-activated zinc silicate with green fluorescence for
short-wave UV (254 nm) and special inorganic fluorescent pig-
ment with blue fluorescence for long-wave UV (366 nm) as
indicators. Fluka silica gel (pore size 60 Å, 70–230 mesh,
63–200 μm) was used for gravity column chromatography. C,
H, N and S elemental microanalyses were carried out on a
Perkin-Elmer 2400-B Series II Analyzer. High-resolution mass
spectra-ESI (HRMS-ESI) were recorded using a Bruker
MicroToF-Q™ equipped with an API-ESI source and a Q-ToF
mass analyzer. Acetonitrile and methanol were used as solvents.
Samples were introduced at a continuous flow of 0.2 mL/min,
and nitrogen served both as the nebulizer gas and the dry gas.
Infrared spectra were recorded on a Spectrum 100 Perkin-Elmer
FTIR spectrophotometer, with a universal attenuated total re-
flectance (UATR) accessory made of thallium bromide-iodide
crystals (KRS-5). The 1H, 13C{1H} and 19F NMR spectra were
recorded on Bruker Avance-300 and -400 spectrometers (δ in
ppm; J in Hz). All spectra were recorded at room temperature in
solution, using CDCl3 as deuterated solvent (different condi-
tions will be indicated). The 1H and 13C{1H} spectra are refer-
enced using the residual solvent signal as internal standard,
while 19F spectra are referenced to CFCl3. The 1H NMR peaks
were assigned through standard 2D 1H−COSY (2K points in t2
using a spectral width of 10 ppm; 128 t1 experiments were re-
corded and zero-filled to 1K; for each t1 value four scans were
signal-averaged using a recycle delay of 1 s) and selective 1D
1H-NOESY experiments. Typical mixing times in the case of
selective 1D-NOESY experiments were in the range 1.2–1.8 s
as a function of the irradiated signal. These optimized mixing
times were set to be equal to the longitudinal relaxation time t1,
determined using the inversion-recovery sequence. The
13C NMR peaks were identified using standard 1H−13C edited-
HSQC and 1H−13C HMBC 2D-experiments. In both cases 4K
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points in t2 using spectral widths of 10 ppm (1H) and 200 ppm
(13C) were used, with averaged values of the coupling con-
stants 1JCH = 145 Hz and long-range nJCH = 10 Hz. Typically,
256 t1 experiments were recorded and zero-filled to 2K. For
each t1 value 8 (HSQC) or 32 (HMBC) scans were signal-aver-
aged using a recycle delay of 1 s. Absorption spectra were
measured on a Thermo Scientific Evolution 600BB spectropho-
tometer. Cinnamoylglycine (1) was prepared by the
Schotten–Baumann method [49].
Irradiation setup for batch synthesis
The irradiation setup consisted of a flask (100 mL) irradiated by
a printed circuit board (PCB) formed by 24 LEDs of 10 mm di-
ameter each LED. The LEDs were serially connected in blocks
of 6, with the minimum voltage possible (3 V) and a resistance
of 60 Ω (according to Ohm's law). The output power per LED
unit (blue, 465 nm) was 250 kmcd; the optical output power of
the PCB of LEDs measured with a photometer (PM100D, Thor-
labs) was 1 W. The PCB (dimensions: 7 × 6 cm) and the flask
were placed inside a custom-built set-up for fixing the light
source and the sample container, and dissipating the excess
heat. A concave mirror was placed in front of the PCB to maxi-
mize the light that irradiated the balloon. Light emitting diodes
(LEDs) were purchased from Topbright.
X-ray crystallography
Single crystals of 2c and 4a of suitable quality for X-ray
diffraction measurements were grown by slow diffusion of
n-pentane into CH2Cl2 solutions of the crude product at –18 °C
for several weeks. One selected single crystal was mounted at
the end of a quartz fiber in a random orientation, covered with
perfluorinated oil (magic oil) (2c) or paratone oil (4a) on
MiTeGen microMounts cryoloop and placed under a cold
stream of nitrogen gas. Crystallographic measurements were
carried out at 100 K on Bruker Smart APEX CCD (2c) or
Bruker D8 Venture (4a) diffractometers, using graphite mono-
chromated Mo Kα radiation (λ = 0.71073 Å). A hemisphere of
data was collected in each case based on ω-scan or φ-scan runs.
The diffraction frames were integrated using the program
SAINT [67] and the integrated intensities were corrected for
absorption with SADABS [68]. The structures were solved and
developed by Patterson and Fourier methods [69]. All non-
hydrogen atoms were refined with anisotropic displacement pa-
rameters. The hydrogen atoms were placed at idealized posi-
tions and treated as riding atoms. Each hydrogen atom was
assigned an isotropic displacement parameter equal to 1.2–1.5
times the equivalent isotropic displacement parameter of its
parent atom. For structure solving and refinement the SHELX-
97 [70], and Bruker APEX3 software package [71] were used.
The structures were refined to Fo2, and all reflections were used
in the least-squares calculations [70] CCDC-1991019 (2c) and
-1991018 (4a) contain the supplementary crystallographic data
for this paper. These data can be obtained free of charge from
the Cambridge Crystallographic Data Centre via http://
www.ccdc.cam.ac.uk/data_request/cif.
General synthesis of the 4-((Z)-arylidene)-2-
((E)-styryl)-5(4H)-oxazolones 2a–j
The oxazolones 2a–j were prepared following the general
Erlenmeyer–Plöchl method reported in the literature [42-48]. To
a solution of N-cinnamoylglycine (1, 1.000 mg, 4.87 mmol) in
acetic anhydride (5 mL), sodium acetate (400 mg, 4.87 mmol)
and the corresponding benzaldehyde (4.87 mmol) were added.
The resulting suspension was heated to 110 °C for 2 h and then
allowed to cool to room temperature. The resulting deep yellow
precipitate was stirred with ethanol (25 mL), filtered off,
washed with water (20 mL), additional ethanol (25 mL) and
diethyl ether (20 mL), and dried by suction. The resulting
yellow solid was characterized as the corresponding oxazolone
2a–j.
Characterization of 4-((Z)-4-fluorobenzylidene)-2-((E)-
styryl)oxazol-5(4H)-one (2b): Following the general proce-
dure, 1 (1000 mg, 4.87 mmol) was reacted with 4-fluorobenzal-
dehyde (0.513 mL, 4.87 mmol) and sodium acetate (400 mg,
4.87 mmol) in acetic anhydride (5 mL) to give 2b as a yellow
solid. Obtained: 577 mg, 1.969 mmol, 40% yield. 1H NMR
(300.13 MHz, CDCl3) δ 8.16 (m, 2H, H2', H6', C6H4F), 7.70 (d,
J = 16.2 Hz, 1H, Hβ), 7.59 (m, 2H, Ho, C6H5), 7.49–7.38 (m,
3H, Hm, Hp, C6H5), 7.22–7.08 (m, 3H, H3', H5', C6H4F, Hvin),
6.81 (d, J = 16.2 Hz, 1H, Hα); 13C{1H} NMR (75.47 MHz,
CDCl3) δ 167.3 (s, C=O), 164.3 (d, 1JCF = 255.1 Hz, C-F,
C6H4F), 163.6 (s, C=N), 144.2 (s, CH, =Cβ), 134.7 (d, 3JCF =
8.5 Hz, CH, C6H4F), 133.3 (s, =C), 133.3 (s, C, Cipso, C6H5),
131.0 (s, CH, Cp, C6H5), 130.1 (d, 4JCF = 3.4 Hz, C, C6H4F),
129.9 (d, 5JCF = 1.6 Hz, =CH, Cvin), 129.3 (s, CH, Cm, C6H5),
128.3 (s, CH, Co, C6H5), 116.3 (d, 2JCF = 22.3 Hz, CH,
C6H4F), 113.4 (s, CH, =Cα); 19F NMR (282.40 MHz, CDCl3) δ
−106.71 (tt, J = 8.5, 5.6 Hz); HRMS (ESI+) m/z: [M + Na]+:
calcd for C18H12FNNaO2, 316.0750; found, 316.0719; IR (ν,
cm−1): 1782 (νC=O), 1655 (νC=N).
General synthesis of the ortho-palladated
derivatives 3a–f, 3h–j
In a similar manner as described in [30], to a solution of the
oxazolones 2a–j in CF3CO2H (8 mL), the stoichiometric
amount of Pd(OAc)2 (1:1 molar ratio) was added. The resulting
mixture was heated at 75 °C for 2 h with stirring. During this
time, the color of the suspension changed from yellow to
reddish, and an increase in the amount of precipitated red solid
was evident. After the reaction time the mixture was cooled to
room temperature and distilled water (10 mL) was added. The
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resulting reddish solid was filtered off, washed with additional
portions of distilled water until the smell of the trifluoroacetic
acid disappeared (in general 3 × 10 mL was sufficient, but a
larger amount could be necessary), dried in vacuo and charac-
terized as the orthopalladated dimers 3a–f and 3h–j.
Characterization of ortho-palladated complex 3b: Following
the general method, oxazolone 2b (200 mg, 0.683 mmol) was
reacted with Pd(OAc)2 (153 mg, 0.683 mmol) in CF3CO2H
(8 mL) to give 3b as a reddish solid. Obtained: 332 mg,
0.324 mmol, 95% yield. 1H NMR (300.13 MHz, CDCl3) δ 7.57
(m, 2H, Ho, C6H5), 7.49 (d, J = 16.1 Hz, 1H, Hβ), 7.49–7.39
(m, 3H, Hm, Hp, C6H5), 7.30 (s, 1H, Hvin), 7.21 (dd, J = 8.4, 6.1
Hz, 1H, H2', C6H3F), 7.04 (d, J = 15.9 Hz, 1H, Hα), 6.87 (td, J =
7.9, 2.4 Hz, 1H, H3', C6H3F), 6.81 (dd, J = 10.1, 2.4 Hz, 1H,
H5', C6H3F); 13C{1H} NMR (75.47 MHz, CDCl3) δ 166.2 (q,
2JCF = 39.1 Hz, C, CO2CF3), 165.7 (s, C=N), 161.8 (d, 1JCF =
247.1 Hz, C–F, C6H3F), 160.0 (s, C=O), 149.2 (s, CH, =Cβ),
137.0 (d, 3JCF = 6.8 Hz, C, C6H3F), 135.4 (s, CH, =Cvin), 134.1
(d, 3JCF = 8.7 Hz, CH, C6H3F), 133.5 (s, C, Cipso, C6H5), 132.5
(s, CH, Cp, C6H5), 129.3 (s, CH, Co, C6H5), 129.2 (s, CH, Cm,
C6H5), 126.2 (d, 4JCF = 2.8 Hz, C, C6H3F), 122.0 (d, 6JCF =
2.6 Hz, =C), 120.5 (d, 2JCF = 22.3 Hz, CH, C6H3F), 115.0 (q,
1JCF = 288.4 Hz, C, CF3), 113.5 (d, 2JCF = 23.1 Hz, CH,
C6H3F), 109.8 (s, CH, =Cα); 19F NMR (282.40 MHz, CDCl3) δ
−74.77 (s, CF3), −102.95 (ddd, J = 10.2, 7.5, 6.0 Hz, F4',
C6H3F). HRMS (ESI+) m/z: [M − COOCF3 + CH3O + Na]+
calcd. for, C38H28F2N2NaO6Pd2 882.9887; found, 882.9908; IR
(ν, cm−1): 1791 (νC=O), 1653 (νC=N), 1190 (νCF3).
General synthesis of the ortho-palladated
cyclobutanes 4a–f, 4h–j
The ortho-palladated dimers 3 (amount specified in each case)
were suspended in CH2Cl2 (20–40 mL). The suspension was
stirred at room temperature while irradiating with blue light
(465 nm, see ‘irradiation setup’ section) for 48 h. As a rule of
thumb, the initial suspension dissolved as the reaction
progressed, and a clear solution was obtained after the reaction
time. In a few cases some evidence of decomposition (presence
of black Pd0) was observed. This was removed by filtration
through a bed of Celite®. The resulting clear solution was evap-
orated to dryness to afford the corresponding ortho-palladated
cyclobutanes 4 as deep yellow solids.
Characterization of ortho-palladated cyclobutane 4b:
Following the general method, ortho-palladated 3b (250 mg,
0.244 mmol) in CH2Cl2 (20 mL) was irradiated with blue light
(465 nm) for 48 h to give ortho-palladated cyclobutane 4b as a
yellow solid. Obtained: 228 mg, 0.223 mmol, 91% yield.
1H NMR (300.13 MHz, CDCl3) δ 7.73 (d, J = 16.0 Hz, 1H, Hβ),
7.67 (m, 2H, Ho, C6H5), 7.57 (d, J = 16.0 Hz, 1H, Hα),
7.53–7.43 (m, 3H, Hm, Hp, C6H5), 6.86 (dd, J = 9.3, 2.4 Hz,
1H, H5', C6H3F), 6.78 (dd, J = 8.3, 5.6 Hz, 1H, H2', C6H3F),
6.71 (td, J = 8.0, 2.4 Hz, 1H, H3', C6H3F), 4.95 (s, 1H, CH
cyclobutane); 13C{1H} NMR (75.47 MHz, CDCl3) δ 172.2 (s,
C=O), 168.9 (s, C, C2, C=N), 167.2 (q, 2JCF = 36.4 Hz, C,
CO2CF3), 160.1 (d, 1JCF = 253.7 Hz, C-F, C6H3F), 151.2 (s,
CH, =Cβ), 137.4 (d, 3JCF = 6.2 Hz, C, C6H3F), 133.3 (s, C,
Cipso, C6H5), 133.0 (s, CH, Cp, C6H5), 130.0 (d, 3JCF = 8.1 Hz,
CH, C6H3F), 129.6 (s, CH, Cm, C6H5), 129.6 (s, CH, Co,
C6H5), 123.5 (d, 4JCF = 2.9 Hz, C, C6H3F), 120.5 (d, 2JCF =
22.1 Hz, CH, C6H3F), 115.3 (q, 1JCF = 287.5 Hz, C, CF3) 113.2
(d, 2JCF = 22.3 Hz, CH, C6H3F), 110.9 (s, CH, =Cα), 69.0 (s, C,
cyclobutane), 59.5 (s, CH, cyclobutane); 19F NMR (282.40
MHz, CDCl3) δ −74.60 (s, 3F, CF3), −110.53 (ddd, J = 9.0, 8.0,
5.7 Hz, 1F, Far); anal. calcd for C40H22F8N2O8Pd2: C, 46.94;
H, 2.17; N, 2.74; found: C, 46.81; H, 2.28; N, 2.94; IR (ν,
cm−1): 1836 (νC=O), 1652 (νC=N), 1191 (νCF3).
General synthesis of the ortho-methoxycar-
bonylated 1,3-diaminotruxillics 5
The ortho-palladated cyclobutanes 4 (4b, 4d, 4f, 4h, 4j) were
dissolved in a mixture of methanol and acetonitrile (1:3 ratio
MeOH/NCMe). The solution was stirred under a CO atmo-
sphere (1 atm; balloon) for 16 h. During the reaction time the
decomposition of the organopalladium complex was evident as
black Pd0 was formed. After the reaction time the resulting
black suspension was filtered through a Celite® pad to give a
yellow solution. The Celite® was washed with additional
NCMe (10 mL) and the combined solutions were evaporated to
dryness to afford the corresponding ortho-methoxycarbony-
lated 1,3-diaminotruxillic derivatives (5b, 5d, 5f, 5h, 5j) as
yellow solids.
Characterization of dimethyl 1,3-dicinnamamido-2,4-bis(4-
fluoro-2-(methoxycarbonyl)phenyl)cyclobutane-1,3-dicar-
boxylate (5b): Following the general method, a solution of the
ortho-palladated cyclobutane 4b (150 mg, 0.146 mmol) in a
mixture of methanol (5 mL) and NCMe (15 mL) was stirred
under a CO atmosphere (1 atm) for 16 h to give the truxillic
cyclobutane derivative 5b as a pale yellow solid. Obtained:
95 mg, 0.124 mmol, 84% yield. 1H NMR (400.13 MHz,
CDCl3) δ 7.70 (dd, J = 8.9, 5.5 Hz, 1H, H6, C6H3F), 7.52–7.47
(m, 2H, Ho, C6H5), 7.42–7.36 (m, 6H, NH, H3, C6H3F, Hm, Hp,
C6H5, Hβ), 7.09 (m, 1H, H5, C6H3F), 6.40 (d, J = 15.7 Hz, 1H,
Hα), 6.01 (s, 1H, cyclobutane), 4.00 (s, broad, 3H, OMe,
CO2Me cyclobutane), 3.88 (s, 3H, OMe, Ar–CO2Me); 13C{1H}
NMR (75.47 MHz, CDCl3) δ 172.3 (s, CO2Me cyclobutane),
167.9 (s, Ar-CO2Me), 166.6 (s, NHC=O), 161.3 (d, 1JCF =
248.0 Hz, C–F, C6H3F), 142.8 (s, CH, =Cβ), 134.4 (s, C, Cipso,
Ph), 133.6 (d, 3JCF = 7.0 Hz, C, C6H3F), 131.3 (d, 3JCF =
7.8 Hz, CH, C6H3F), 130.4 (s, CH, Cp, Ph), 129.2 (s, C,
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C6H3F), 129.0 (s, CH, Cm, Ph), 128.2 (s, CH, Co, Ph), 119.7 (s,
CH, =Cα), 118.4 (d, 2JCF = 22.0 Hz, CH, C6H3F), 117.2 (d,
2JCF = 23.0 Hz, CH, C6H3F), 65.8 (s, C, cyclobutane), 53.9 (s,
CH, OMe, CO2Me  cyclobutane), 52.7 (s, CH, OMe,
Ar–CO2Me), 48.2 (s, CH, cyclobutane); 19F NMR (282.40
MHz, CDCl3) δ −113.89 (pseudo dt, J = 8.6, 5.8 Hz). HRMS
(ESI+) m/z: [M + Na]+ calcd. for C42H36F2N2NaO10, 789.2236;
found, 789.2245; IR (ν, cm−1): 1723 (νCO2Me).
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